Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophageal Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02638909
What this trial is testing

Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies

Who this might be right for
Colorectal AdenocarcinomaCholangiocarcinomaPancreatic Adenocarcinoma+3 more
Criterium, Inc. 4
Not applicableEnded earlyNCT05579444
What this trial is testing

Systems Biology of Gastrointestinal and Related Diseases

Who this might be right for
Ulcerative ColitisCrohn DiseaseObesity+19 more
Viome 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06468644
What this trial is testing

Phase II Study of Different Doses of Radiotherapy Combined With Sintilimab in the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fujian Cancer Hospital 60
Not applicableStudy completedNCT05524844
What this trial is testing

The Microbiome, Bile Acids, and Notch in Barrett's Esophagus (BE)

Who this might be right for
Barrett EsophagusEsophageal Adenocarcinoma
Columbia University 54
Not applicableUnknownNCT03329534
What this trial is testing

Gluten Related Disorders in Barrett's Esophagus

Who this might be right for
Celiac DiseaseBarrett EsophagusGluten Sensitivity+1 more
McMaster University 40
Not applicableUnknownNCT03418909
What this trial is testing

Functional Outcome After Treatment for Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oropharynx CancerPainSwallowing Disorder+3 more
Rigshospitalet, Denmark 44
Early research (Phase 1)Study completedNCT04641871
What this trial is testing

Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 78
Testing effectiveness (Phase 2)Study completedNCT05864144
What this trial is testing

SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultAdvanced Solid TumorHead and Neck Cancer+19 more
Sensei Biotherapeutics, Inc. 98
Large-scale testing (Phase 3)Not Yet RecruitingNCT06501664
What this trial is testing

Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCC

Who this might be right for
Esophageal Cancer
Rui-hua Xu, MD, PhD 360
Testing effectiveness (Phase 2)UnknownNCT02375581
What this trial is testing

Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
First People's Hospital of Hangzhou 130
Large-scale testing (Phase 3)Not Yet RecruitingNCT07211009
What this trial is testing

Patient-Reported Symptom Care Versus Usual Care After Esophageal Cancer Surgery: A Single-Center Phase 3 Randomized Trial

Who this might be right for
Esophageal Cancer (EsC)
Sichuan University 240
Testing effectiveness (Phase 2)Ended earlyNCT06682806
What this trial is testing

PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation

Who this might be right for
Advanced Solid TumorEsophageal CancerMetastatic Solid Tumor+2 more
Prelude Therapeutics Incorporated 6
Testing effectiveness (Phase 2)Looking for participantsNCT06408116
What this trial is testing

Predicting Esophageal Cancer Borders Using PET-Imaging

Who this might be right for
Esophagus Cancer, Stage IEsophagus Cancer, Stage II
University Hospital Heidelberg 30
Testing effectiveness (Phase 2)UnknownNCT05865132
What this trial is testing

Palbociclib Combined With Afatinib for Advanced Squamous Carcinoma of Esophagus or Gastroesophageal Junction

Who this might be right for
Esophagus Squamous Cell Carcinoma
AIPING ZHOU 30
Early research (Phase 1)Looking for participantsNCT07085091
What this trial is testing

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)HNSCCCRC (Colorectal Cancer)+4 more
ALX Oncology Inc. 170
Testing effectiveness (Phase 2)Ended earlyNCT00539617
What this trial is testing

Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery

Who this might be right for
Esophageal Cancer
University of California, San Francisco 7
Not applicableWithdrawnNCT03546660
What this trial is testing

Imaging of the Esophagus Using a SECM Capsule

Who this might be right for
Eosinophilic EsophagitisBarrett Esophagus
Massachusetts General Hospital
Testing effectiveness (Phase 2)Looking for participantsNCT07733180
What this trial is testing

A Study Investigating Alternate Schedules of Tislelizumab Plus Chemotherapy in Japanese Patients With First-line Advanced ESCC

Who this might be right for
Advanced Esophageal Squamous Cell CarcinomaMetastatic Esophageal Squamous Cell Carcinoma
BeOne Medicines 30
Not applicableStudy completedNCT00943280
What this trial is testing

Barrett's Esophagus in Olmsted County

Who this might be right for
Barrett's Esophagus
Mayo Clinic 60
Testing effectiveness (Phase 2)UnknownNCT00425425
What this trial is testing

Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer

Who this might be right for
Esophageal Cancer
Technical University of Munich 43
Next Page